4Filing Date: Sep 11, 2026

Gilead (GILD)

Statement of Changes in Beneficial Ownership

View SEC Filing
ACC: 0001638643-26-000033
Total Value$612.5K
Trades3
Insiders1

Transaction Details

O'Day Daniel Patrick
Chairman & CEO, Director·Direct
Exercise · Acquire
Common Stock
Shares+8.78K
Price-
Total Value$0
Shares Owned After585.91K
Transaction DateSep 10, 2026
Footnotes ▸

Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

O'Day Daniel Patrick
Chairman & CEO, Director·Direct
Exercise · Dispose
Restricted Stock UnitDerivative
Shares-8.78K
Price-
Total Value$0
Shares Owned After83.30K
Transaction DateSep 10, 2026
Footnotes ▸

Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. | Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. | The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested. | The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested.

O'Day Daniel Patrick
Chairman & CEO, Director·Direct
Tax W/H · Dispose
Common Stock
Shares-4.23K
Price$144.81
Total Value$612.5K
Shares Owned After581.68K
Transaction DateSep 10, 2026

Post-Transaction Holdings

O'Day Daniel Patrick · Chairman & CEO, Director
SecuritySharesChange
Common Stock585.91K+4.55K (0.78%)
Restricted Stock Unit83.30K-8.78K (-9.54%)
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-09-10 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: GILEAD SCIENCES, INC. (GILD) CIK: 0000882095 --- Reporting Owner --- Name: O'Day Daniel Patrick CIK: 0001638643 Role: Director, Officer (Chairman & CEO) --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-09-10 | Code: M (Exercise of derivative) Shares: +8,780 Shares Owned After: 585,913 | Ownership: D (Direct) Footnotes: [F1] Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. [Transaction #2] Security: Common Stock Date: 2026-09-10 | Code: F (Payment of exercise/tax) Shares: -4,230 | Price: $144.81 Total Value: $612,546.30 Shares Owned After: 581,683 | Ownership: D (Direct) --- Derivative Transactions --- [Transaction #1] Security: Restricted Stock Unit Date: 2026-09-10 | Code: M (Exercise of derivative) Shares: -8,780 Shares Owned After: 83,300 | Ownership: D (Direct) Footnotes: [F1] Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. [F1] Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. [F2] The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested. [F2] The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested. --- Footnotes (Complete Index) --- F1: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F2: The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested. --- Signature --- /s/ /s/ Amy Kim by Power of Attorney for Daniel O'Day (2026-09-11)

keid analysis is for reference only and does not constitute investment advice.